Tobby Simon is the Founder, President and CEO of Synergia Bio Sciences, a life sciences company, focused on manufacturing and the design and implementation of strategies to translate early stage research to market. He is also the President of Synergia Foundation, a think tank that works closely with industry, polity and academia to establish leading edge practices through Applied Research in the domains of Business Continuity Planning, Risk and Security Analysis.
A graduate of the Harvard Business School (HBS) and a Research Affiliate at the Massachusetts Institute of Technology (MIT), Tobby has over two decades of senior management experience in the life sciences industry covering broad disciplines including commercial, supply chain management, manufacturing, regulatory , marketing and international business. His professional career began with Hoechst Marion Roussel (HMR). He rapidly rose to become the Commercial Manager of the holding company. Subsequently he joined The Lyka Group as General Manager – Marketing, responsible for both domestic and global markets. His success at Lyka won him industry accolades, including the National Certificate of Merit from Government of India in 1992. He went on to become the Vice President – International Business Division of the group, which was an exceptional achievement by industry standards.
Tobby is also currently the Director of Wintac Limited, one of the few US FDA and EU approved manufacturing sites for Injectible and Ophthalmics in India. Synergia Bio Sciences is the second largest equity holder in Wintac Limited.
A Research Associate at the Massachusetts Institute of Technology, he is currently developing a global template on ‘Risk Management’ with the Center for Transportation and Logistics at MIT. The study aims at providing a deeper understanding of global challenges to help leverage business continuity and better understand the vulnerabilities of supply chain networks with a focus on pharmaceutical industries.
Tobby is currently a research partner with the Indian Institute of Management Bangalore (IIMB), the Indian Institute of Technology, Kanpur (IITK) and the University of Nottingham (UON) on project Bio Pharm 2020 Science Bridge. The project seeks to create a step-change in collaborative innovation, building on extensive industry and academic collaborations. The research will provide insights that can contribute to drug discovery and development, drug delivery, manufacturing and supply chain management of drugs that add value to health and delivery of medical care.
Tobby is a member of the International Council of the Belfer Centre of Science and Technology at The John F. Kennedy School of Government, Harvard University. He is member of the Advisory Board of Centre for New American Security (CNAS) a key Washington based think tank. He is an invitee to The Trilateral Commission and also member of the International Institute for Strategic Studies (IISS). He is also the Regional Director of Harvard Business Schools Health Care Industry Alumni and a member of the World Information Technology Services and Alliance (WITSA).
Tobby is a speaker at various global public policy conferences, World Trade Organization, World Information Technology Forum, Massachusetts Institute of Technology, John F Kennedy School of Government, Council for Foreign Relations (CFR), Indian Institute of Management and Indian Institute of Science.
As part of his commitment to humanitarian causes, Tobby worked closely with Nobel Prize winner, Medicines Sans Frontier, to validate manufacturing facilities of Cipla, Ranbaxy and Aurobindo. Enabling WHO (World Health Organization) to procure less expensive anti-retroviral drugs from India. This project is helping millions of afflicted people in Asia, Africa and South America. He has collaborated with World Bank in critical relief projects, to help the victims of the Gujarat earthquake and the South Asian Tsunami.
Tobby is currently pursuing his PhD at the National Institute of Advanced Studies (NIAS – Indian Institute of Science) and is a Special Professor at the School of Management in the University of Nottingham.